
Adicet Bio, Inc. (ACET)
Last updated: 2026-10-24 15:17:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Adicet Bio, Inc. (ACET) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.98, with a market capitalization of $40.07M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.96 to $14.98. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$40.07M | |
$4.22 | |
$515.20 | |
$2.13 | |
$4.28 | |
157.97K | |
192.45K | |
-- | |
$14.98 | |
$3.96 | |
-- | |
-- |
Adicet Bio, Inc. (ACET) Latest Closing Stock Price
Adicet Bio, Inc. (ACET) last closed at $4.28 as of 2026-10-23 23:46:00, unchanged from the previous close of $4.28.
During the latest regular trading session, ACET traded between $2.13 and $515.20, with a volume of 157.97K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Adicet Bio, Inc. (ACET) 7-Day Stock Price Change
Over the past seven days, Adicet Bio, Inc. (ACET) moved from $5.14 to $3.98, representing a decline of 22.67% ($1.16).
The stock traded between $3.96 and $5.17 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 171.84 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
ACET 52-Week Price Position
Position in Range: 0.1%
ACET is currently trading at $3.98, placing it 0.1% of the way from its 52-week low of $3.96 to its 52-week high of $14.98. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Adicet Bio, Inc. (ACET)?
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).
Adicet Bio, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 102 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Adicet Bio, Inc. (ACET) Stock on MEXC
Eligible investors can buy real shares of Adicet Bio, Inc. (ACET) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Adicet Bio, Inc. (ACET) stock price today?
2.Is ACET stock going up or down today?
3.What is ACET pre-market price?
4.What is ACET after-hours price?
5.Is ACET stock trading now?
6.Where does ACET sit relative to its 52-week high and low?
7.What sector is Adicet Bio, Inc. in?
8.What is Adicet Bio, Inc.'s market capitalization and where is it listed?
9.How is ACET valued in terms of P/E ratio and EPS?
10.Does Adicet Bio, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
ACET Stock Calculator
Estimate the value between ACET shares and USD.
ACET Shares to USD
1.00 ACET shares = 3.975 USD
Calculations are estimates based on the latest available price and are for reference only.


